Latest Breaking News On - Intrommune therapeutics - Page 1 : comparemela.com

Intrommune Therapeutics Presents Oral Mucosal Immunotherapy Updates at Leading Industry Events

Intrommune Therapeutics Presents Oral Mucosal Immunotherapy Updates at Leading Industry Events
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkJersey cityNew jerseyMichael nelsonStuart loeschDrug administrationIntrommune therapeutics incIntrommune executive teamFood allergy fund summitTechnology companies ceosLeading industryScience conferencePartnering conferenceAnnual food allergy fundNew york city

Peanut Allergy Drug Landscape Analysis Report 2024:

Dublin, April 11, 2024 (GLOBE NEWSWIRE) The

Intrommune therapeuticsRoute of administrationPeanut allergyAllergy therapeuticspolyvacPhasei stageResearch and marketsLlergy immunotherapiesAllergy immunotherapyPeanut allergy drugEanut allergy pipeline Peanut allergy treatment

Toothpaste provides oral mucosal immunotherapy for peanut allergy

Toothpaste provides oral mucosal immunotherapy for peanut allergy
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesByrichard gawelWilliame bergerKristen dowdAmerican academy of allergyAllergy asthma solutionsAmerican academyImmunology annualAsthma solutionsIntrommune therapeutics

Intrommune Therapeutics Strengthens Board of Directors with Appointments of Dr. Jonathan Rich and Hem Pandya

Intrommune Therapeutics Strengthens Board of Directors with Appointments of Dr. Jonathan Rich and Hem Pandya
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesMichael nelsonJen zollerStuart loeschGreen room communicationsPharmaceuticals incGirls club of america mercerMayne pharmaceuticalsAustralian companyIntrommune therapeutics incStrides pharmaceuticals incAnodyne nanotech incExchange healthIsles foundationMuseum at rutgers universityHead of the generic products division

Study Suggest Oral Mucosal Immunotherapy May Offer Safer, More Convenient Option

This analysis presented at AAAAI suggests that the experimental OMIT delivery of allergens via toothpaste may allow for a safer alternative to other immunotherapies.

United statesWilliame bergerAmerican academy of allergyDrug administrationIntrommune therapeutics incIntrommune therapeuticsAnnual scientific meeting